Takahiro Osawa

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet · 2017 · 175 citations · Full text

Platinum-based Therapy, Urology, Metastatic Urothelial Carcinoma +8

Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial

Sumanta K. Pal, Laurence Albigès, Piotr Tomczak et al. · The Lancet · 2023 · 173 citations · Full text

Urology, Genitourinary Cancer, Medicine +7

Heterogeneity of Tumor Endothelial Cells

Noritaka Ohga, Shuhei Ishikawa, Nako Maishi et al. · American Journal Of Pathology · 2012 · 163 citations · Full text

Angiogenesis, Tumor Endothelial Cells, Biological Microenvironments +6

Tumor-Derived Microvesicles Induce Proangiogenic Phenotype in Endothelial Cells via Endocytosis

Taisuke Kawamoto, Noritaka Ohga, Kosuke Akiyama et al. · PLoS ONE · 2012 · 100 citations · Full text

Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells

Kazuhiro Yamamoto, Noritaka Ohga, Yasuhiro Hida et al. · British Journal of Cancer · 2012 · 100 citations · Full text